| Financial Year |
March 31 2023 |
| Monetary Funds |
5,322,223,728.49 |
| Held-for-trading Financial Assets |
1,582,760,181.11 |
| Notes Receivable |
131,142,839.16 |
| Accounts Receivable |
5,545,155,101.99 |
| Advances to Suppliers |
375,795,545.13 |
| Other Receivables |
20,743,063.35 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,685,837,894.22 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
277,377,784.86 |
| Total Current Assets |
16,227,587,524.25 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
62,039,168.39 |
| Fixed Assetes |
2,182,244,065.52 |
| Under-construction Projects |
843,955,009.77 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
189,917,614.68 |
| R&D expenses |
-- |
| Goodwill |
22,944,497.11 |
| Long-Term Deferred and Prepaid Expenses |
3,099,651.07 |
| Deferred Income Tax Assets |
107,899,582.51 |
| Other Non-Current Assets |
180,669,004.50 |
| Sub-Total of Non-Current Assets |
3,612,292,245.58 |
| Total Assets |
19,839,879,769.83 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
4,648,522,307.30 |
| Accounts Payable |
2,444,154,597.66 |
| Accounts Received In Advance |
554,444.24 |
| Employee Compensation Payable |
249,802,980.07 |
| Taxes Payable |
79,236,318.29 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
9,985,449.48 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
22,072,510.20 |
| Other Current Liabilities |
5,765,303.22 |
| Sub-Total of Current Liabilities |
7,508,183,544.26 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
29,512,642.75 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
63,587,636.98 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
308,932,166.18 |
| Total Liabilities |
7,817,115,710.44 |
| Paid-In Capital(Or Share Stock) |
506,500,774.00 |
| Capital Surplus |
7,162,582,261.10 |
| Surplus Reserve |
98,431,969.24 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
4,153,198,218.22 |
| Minority Stockholder's Interest |
102,023,888.13 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
11,920,740,171.26 |
| Owner's Equity（Stockholder's Equity） |
12,022,764,059.39 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
19,839,879,769.83 |
